शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
CHEMPLASTSBSECHEMPLAST SANMAR LIMITED· Chemicals & PetrochemicalsHighNeutral
Announced Thu, 27 Aug, 2026 · 17:40 IST

Central Government approves S Ganeshkumar as Managing Director

CHEMPLASTS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.3%Reaction day
₹178.20
prior close
₹178.50
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+2.0% vs market
Specialty Chemicals peers, median of 103sector+0.5%+1.9% vs sector

On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 1.9 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+2.9
10m
+3.1
15m
+4.6
30m
+3.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.3+0.3+2.0+0.5+1.9
Next day
-1.2+0.6-1.8-0.0-1.2
2d
-4.8-0.4-4.4-0.4-4.4
3d
-4.8-0.9-3.8-0.3-4.5
4d
-6.0-0.3-5.7+0.3-6.3
5d
-4.6+0.3-4.9+0.8-5.4
1w
+1.0+1.3-0.3+1.6-0.6
15d
+1.6-0.1+1.7-0.8+2.3
1m
+9.6-1.2+10.8+0.5+9.1
2m
+10.9-7.7+18.6-6.2+17.1
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 103Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Chemplast Sanmar received Central Government (MCA) approval for the appointment of Mr S Ganeshkumar (DIN 00088163) as Managing Director for 3 years effective April 1, 2026. Approval follows the board meeting on January 10, 2026 and postal ballot on March 23, 2026. The MCA letter dated August 24, 2026 was received on August 27, 2026.

Likely market impact

Leadership clarity - 3 year MD term now formally approved, removing regulatory uncertainty from earlier board approval.